2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
|
|
|
- CAS-Nr.
- 32384-65-9
- Englisch Name:
- 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
- Synonyma:
- 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone;D-Gluconic acid, 2,3,4,6-tetrakis-O-(triMethylsilyl)-, δ-lactone;Dagliptin Impurity;oxy)-6-((triMethyL;Cagliflozin Impurity 9;Englitazinintermediate;Dapagliflozin Impurity 12;Canagliflozin Related Impurity 9;(3R,4S,5R,6R)-3,4,5-tris(triMethyL;Canagliflozin Impurity 9(Dagelin impurity 11)
- CBNumber:
- CB32610563
- Summenformel:
- C18H42O6Si4
- Molgewicht:
- 466.87
- MOL-Datei:
- 32384-65-9.mol
|
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Eigenschaften
- Siedepunkt:
- 417℃
- Dichte
- 0.97
- Flammpunkt:
- 171℃
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- Löslichkeit
- Chloroform (Sparingly), Ethyl Acetate (Slightly), Methanol (Slightly)
- Aggregatzustand
- Oil
- Farbe
- Colourless to Pale Yellow
- Stabilität:
- Moisture Sensitive
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale yellow oil
Verwenden
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone is an antidiabetic agent and an intermediate of Dapagliflozin (D185370). 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone acts as a reagent in the synthesis of trans-cyclohexane-bearing C-glucose as sodium glucose co-transporter 2 inhibitors.
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 454)Lieferanten
32384-65-9()Verwandte Suche:
- (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one
- (3R,4S,5R,6R)-3,4,5-Tris[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]tetrahydropyran-2-one
- D-2,3,4,6-Tetrakis-O-(trimethylsilyl)-gluconic acid delta-lactone
- 2,3,4,6-Tetrakis-O-triMethylsilyl-D-gluconolactoe
- D-Gluconic acid, 2,3,4,6-tetrakis-O-(triMethylsilyl)-, d-lactone
- 2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono1,5 lactone
- (3R,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one
- (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan-2-one
- 2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactone
- Dapagliflozin Impurity 12
- Cagliflozin Impurity 9
- 32384-65-9 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
- (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan-2-one 32384-65-9
- (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyl)oxy)-6-((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 97%
- 2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-delta-lactone
- (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-(trimethylsilyloxymethyl)oxan
- Dagliptin Impurity
- (3R,4S,5R,6R)-3,4,5-tris(triMethyL
- oxy)-6-((triMethyL
- Canagliflozin Related Impurity 9
- 2,3,4,6, tetrakis-O-(trimethylsilyl)-D-lactone,
- 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone(For export only)
- (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one ISO 9001：2015 REACH
- Empagliflozin intermediates，2,3,4,6-Tetrakis-O-trimethylsilyl-D- gluconolactone
- 2,3,4,5-Tetrakis-O-trimethylsilyl-D-gluconolactone
- 5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one
- D-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, .delta.-lactone
- 2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactoneQ: What is
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactone Q: What is the CAS Number of
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactone Q: What is the storage condition of
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactone Q: What are the applications of
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactone
- 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
- D-Gluconic acid, 2,3,4,6-tetrakis-O-(triMethylsilyl)-, δ-lactone
- 3,4,5-Tris[(trimethyl silyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}tetrahydro-2H-pyron-2-one
- Englitazinintermediate
- Boronicacid,B-(1,6-dihydro-6-oxo-9-pyridinyl)-
- (3R,4S,5R,6R)-3,4,5-tri ((trimethyl)
Methylsilane)oxy)-6-(((trimethylmethylmethyl
Silic alkyl)oxy group) field group) four atmosphere-2H-pyrid
N?m-2-ketone
- (3R, 4S, 5R, 6R)-3,4,5-tri ((trimethyl)Methylsilane)oxy)-6-(((trimethylmethylmethyl
Silicyl)oxy)methyl)tetrahydr-2H-pyridium
N?m-2-ketone
- (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one,95%
- 2,3,4,6- tetra -O- trimethylsilyl -D- gluconolactone
- D-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, δ-lactone
- (3R,4S,5R,6R)-3,4,5-tris(TMS-oxy)-6-[(TMS-oxy)methyl]tetrahydro-2H-pyran-2-one/D-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, δ-lactone
- 2,3,4,6-tetra-O-Trimethylsilyl-beta-D-glucolactone
- Canagliflozin Impurity 9(Dagelin impurity 11)
- 2,3,4,6-tetra-O-trimethylsilyl-β-d-
gluconolactone
- (3R,4S,5R,6R)-3,4,5-
Tri[(trimethylsilyl)oxy]-6- [[(Trimethylsilyl)oxy] methyl]tetrahydro-2H-pyran- 2-one
- 2,3,4,6-tetra-O-Trimethyl silyl-beta-D-glucolacto Commercial
- 32384-65-9
- 32384-69-5
- C18H42O6Si4
- 32384-65-9
